Log in

MAXIMUS Stock Forecast, Price & News

+0.32 (+0.48 %)
(As of 09/25/2020 12:00 AM ET)
Today's Range
Now: $67.67
50-Day Range
MA: $74.99
52-Week Range
Now: $67.67
Volume348,676 shs
Average Volume427,357 shs
Market Capitalization$4.15 billion
P/E Ratio20.44
Dividend Yield1.66%
MAXIMUS, Inc. provides business process services (BPS) to government health and human services programs worldwide. The company's Health Services segment offers various BPS, appeals, and assessments for state, provincial, and national government programs, including Medicaid, Children's Health Insurance Program, Affordable Care Act, Health Insurance British Columbia, Health Assessment Advisory Service contract, and Preadmission Screening and Resident Reviews. This segment offers program eligibility support and enrollment; application assistance and independent health plan enrollment counseling; beneficiary outreach, education, eligibility, enrollment, and renewal; document and record management; payment processing and administration; and digital eHealth and wellbeing solutions. It also provides independent disability, long-term sick, and other health assessment; occupational health clinical assessment; specialized consulting; and centralized multilingual customer contact centers and multichannel self-service options for enrollment. The company's U.S. Federal Services segment offers centralized citizen engagement centers and support services; document and record management; case management, citizen engagement, and consumer education; independent medical reviews and worker's compensation benefit appeals; and Medicare and Medicaid appeals, and program eligibility appeals. It also provides modernization of systems and information technology infrastructure; infrastructure operations and support services; software development, operations, and management services; and data analytics services. The company's Human Services segment offers national, state, provincial, and local human services agencies, as well as various BPS and related consulting services. It also provides management tools and professional consulting, program consulting, and tax credit and employer services. The company was founded in 1975 and is headquartered in Reston, Virginia.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 2.5Insider Behavior: 1.0Valuation: 1.3 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.15 out of 5 stars

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Sub-IndustryData Processing & Outsourced Services



Sales & Book Value

Annual Sales$2.89 billion
Cash Flow$4.80 per share
Book Value$19.56 per share


Net Income$240.82 million


Market Cap$4.15 billion
Next Earnings Date11/17/2020 (Estimated)
+0.32 (+0.48 %)
(As of 09/25/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MMS News and Ratings via Email

Sign-up to receive the latest news and ratings for MMS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

MAXIMUS (NYSE:MMS) Frequently Asked Questions

How has MAXIMUS's stock been impacted by COVID-19?

MAXIMUS's stock was trading at $60.94 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, MMS shares have increased by 11.0% and is now trading at $67.67.
View which stocks have been most impacted by COVID-19

Do Wall Street analysts recommend investors buy shares of MAXIMUS?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MAXIMUS in the last year. There are currently 1 hold rating, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for MAXIMUS

When is MAXIMUS's next earnings date?

MAXIMUS is scheduled to release its next quarterly earnings announcement on Tuesday, November 17th 2020.
View our earnings forecast for MAXIMUS

How were MAXIMUS's earnings last quarter?

MAXIMUS, Inc. (NYSE:MMS) posted its earnings results on Thursday, August, 6th. The health services provider reported $1.04 earnings per share for the quarter, beating the consensus estimate of $0.78 by $0.26. The health services provider had revenue of $901.34 million for the quarter, compared to the consensus estimate of $801.31 million. MAXIMUS had a return on equity of 17.29% and a net margin of 6.41%. The company's revenue for the quarter was up 23.4% on a year-over-year basis. During the same period last year, the business posted $0.97 earnings per share.
View MAXIMUS's earnings history

How often does MAXIMUS pay dividends? What is the dividend yield for MAXIMUS?

MAXIMUS announced a quarterly dividend on Tuesday, July 7th. Stockholders of record on Friday, August 14th will be paid a dividend of $0.28 per share on Monday, August 31st. This represents a $1.12 dividend on an annualized basis and a dividend yield of 1.66%. The ex-dividend date of this dividend is Thursday, August 13th.
View MAXIMUS's dividend history

What guidance has MAXIMUS issued on next quarter's earnings?

MAXIMUS updated its FY20 earnings guidance on Thursday, August, 6th. The company provided earnings per share (EPS) guidance of $3.20 to $3.30 for the period, compared to the Thomson Reuters consensus estimate of $3.02. The company issued revenue guidance of $3.375 billion to $3.425 billion, compared to the consensus revenue estimate of $3.19 billion.

What price target have analysts set for MMS?

3 Wall Street analysts have issued 1 year target prices for MAXIMUS's stock. Their forecasts range from $81.00 to $90.00. On average, they anticipate MAXIMUS's share price to reach $85.00 in the next twelve months. This suggests a possible upside of 25.6% from the stock's current price.
View analysts' price targets for MAXIMUS

Are investors shorting MAXIMUS?

MAXIMUS saw a decline in short interest in September. As of September 15th, there was short interest totaling 1,230,000 shares, a decline of 9.6% from the August 31st total of 1,360,000 shares. Based on an average daily volume of 327,200 shares, the short-interest ratio is currently 3.8 days. Approximately 2.0% of the company's shares are short sold.
View MAXIMUS's Short Interest

Who are some of MAXIMUS's key competitors?

What other stocks do shareholders of MAXIMUS own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MAXIMUS investors own include Pfizer (PFE), Lennar (LEN), AbbVie (ABBV), Cisco Systems (CSCO), Kroger (KR), Skyworks Solutions (SWKS), Advanced Micro Devices (AMD), Cerner (CERN), Intel (INTC) and JD.Com (JD).

Who are MAXIMUS's key executives?

MAXIMUS's management team includes the following people:
  • Mr. Bruce L. Caswell, Pres, CEO & Director (Age 52)
  • Mr. Richard A. Montoni, Vice Chairman & Sr. Advisor to the CEO (Age 67)
  • Mr. Richard J. Nadeau, CFO & Treasurer (Age 64)
  • Mr. David R. Francis, Gen. Counsel & Sec. (Age 58)
  • Mr. Mark S. Andrekovich, Chief of Human Capital and Former Pres of Tax & Employer Services (Age 57)

What is MAXIMUS's stock symbol?

MAXIMUS trades on the New York Stock Exchange (NYSE) under the ticker symbol "MMS."

Who are MAXIMUS's major shareholders?

MAXIMUS's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (11.14%), Victory Capital Management Inc. (6.42%), William Blair Investment Management LLC (2.43%), Bank of New York Mellon Corp (1.69%), APG Asset Management N.V. (1.35%) and Mondrian Investment Partners LTD (1.27%). Company insiders that own MAXIMUS stock include David Francis, Mark Andrekovich, Paul R Lederer, Raymond B Ruddy, Richard A Montoni, Russell A Beliveau and Thomas D Romeo.
View institutional ownership trends for MAXIMUS

Which institutional investors are selling MAXIMUS stock?

MMS stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, State of Michigan Retirement System, Victory Capital Management Inc., Vanguard Group Inc., Charles Schwab Investment Management Inc., UBS Group AG, Handelsbanken Fonder AB, and AJO LP. Company insiders that have sold MAXIMUS company stock in the last year include David Francis, Richard A Montoni, Russell A Beliveau, and Thomas D Romeo.
View insider buying and selling activity for MAXIMUS

Which institutional investors are buying MAXIMUS stock?

MMS stock was acquired by a variety of institutional investors in the last quarter, including William Blair Investment Management LLC, Copeland Capital Management LLC, Pier Capital LLC, Nordea Investment Management AB, DekaBank Deutsche Girozentrale, WINTON GROUP Ltd, RK Capital Management LLC, and ClariVest Asset Management LLC.
View insider buying and selling activity for MAXIMUS

How do I buy shares of MAXIMUS?

Shares of MMS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MAXIMUS's stock price today?

One share of MMS stock can currently be purchased for approximately $67.67.

How big of a company is MAXIMUS?

MAXIMUS has a market capitalization of $4.15 billion and generates $2.89 billion in revenue each year. The health services provider earns $240.82 million in net income (profit) each year or $3.72 on an earnings per share basis. MAXIMUS employs 29,600 workers across the globe.

What is MAXIMUS's official website?

The official website for MAXIMUS is www.maximus.com.

How can I contact MAXIMUS?

MAXIMUS's mailing address is 1891 METRO CENTER DRIVE, RESTON VA, 20190. The health services provider can be reached via phone at 703-251-8500 or via email at [email protected]

This page was last updated on 9/27/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.